新東方在線(01797.HK)折讓7%配股予控股股東及主席 淨籌17.8億元
新東方在線(01797.HK)公布,向控股股東新東方及主席俞敏洪合共配售5,943.2萬股,佔擴大後股本5.95%,每股配售價3.87美元(約30港元),較昨日收市價折讓將7.3%;總認購額為2.3億美元(折合約17.83億港元)。
公司預計,所得款項淨額估計約為17.81億元,當中約40%將用於繼續改善及落實銷售及營銷活動,以擴大其學生基礎及提高學生入讀率;約40%將用於投資改進及升級技術基礎設施;約10%將用於集團教師及教職員工;及餘下約10%將用作營運資金及其他一般公司用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.